1-119925578-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024408.4(NOTCH2):​c.4238T>A​(p.Leu1413His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00469 in 1,614,042 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 24 hom. )

Consequence

NOTCH2
NM_024408.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 1.40

Publications

13 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061614215).
BP6
Variant 1-119925578-A-T is Benign according to our data. Variant chr1-119925578-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 134975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00369 (561/152164) while in subpopulation AMR AF = 0.00615 (94/15288). AF 95% confidence interval is 0.00514. There are 1 homozygotes in GnomAd4. There are 246 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 561 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.4238T>A p.Leu1413His missense_variant Exon 25 of 34 ENST00000256646.7 NP_077719.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.4238T>A p.Leu1413His missense_variant Exon 25 of 34 1 NM_024408.4 ENSP00000256646.2

Frequencies

GnomAD3 genomes
AF:
0.00369
AC:
561
AN:
152046
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00106
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00616
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00554
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00331
AC:
829
AN:
250810
AF XY:
0.00350
show subpopulations
Gnomad AFR exome
AF:
0.000995
Gnomad AMR exome
AF:
0.00341
Gnomad ASJ exome
AF:
0.00756
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00515
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00479
AC:
7008
AN:
1461878
Hom.:
24
Cov.:
33
AF XY:
0.00472
AC XY:
3434
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.00398
AC:
178
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00849
AC:
222
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000348
AC:
30
AN:
86258
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53404
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.00561
AC:
6238
AN:
1112012
Other (OTH)
AF:
0.00475
AC:
287
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
459
918
1378
1837
2296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00369
AC:
561
AN:
152164
Hom.:
1
Cov.:
32
AF XY:
0.00331
AC XY:
246
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00106
AC:
44
AN:
41530
American (AMR)
AF:
0.00615
AC:
94
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5144
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00554
AC:
377
AN:
67994
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00542
Hom.:
0
Bravo
AF:
0.00470
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00454
AC:
39
ExAC
AF:
0.00295
AC:
358
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 12, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32859249)

Aug 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOTCH2: BP4, BS1, BS2

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:2Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Dec 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 18, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hajdu-Cheney syndrome Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOTCH2-related disorder Benign:1
Sep 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Uncertain
0.62
D
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.15
T
M_CAP
Benign
0.0066
T
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.58
N
PhyloP100
1.4
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.059
Sift
Benign
0.040
D
Sift4G
Benign
0.17
T
Vest4
0.21
ClinPred
0.0071
T
GERP RS
3.3
Varity_R
0.17
gMVP
0.49
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41313282; hg19: chr1-120468201; COSMIC: COSV56681418; COSMIC: COSV56681418; API